Close

Autolus Therapeutics (AUTL) Receives PRIME designation for AUTO1 for the treatment of adult ALL

Go back to Autolus Therapeutics (AUTL) Receives PRIME designation for AUTO1 for the treatment of adult ALL
(NASDAQ: AUTL) Delayed: 4.90 --0 (-0%)
Previous Close $4.90    52 Week High
Open $4.90    52 Week Low
Day High $4.90    P/E N/A 
Day Low $4.90    EPS
Volume 16,248